TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | -11.03%72.59B | -12.10%48.11B | -11.72%24.19B | -5.43%107.48B | -4.26%81.59B | -3.43%54.73B | -1.83%27.4B | 1.34%113.66B | 1.46%85.22B | 1.39%56.68B |
-Interest income | -5.97%177.18B | -4.40%119.52B | -2.03%60.91B | 3.94%250.81B | 5.09%188.42B | 5.59%125.02B | 5.98%62.18B | 5.22%241.31B | 4.83%179.3B | 4.70%118.4B |
-Interest expense | 2.10%-104.59B | -1.60%-71.41B | -5.60%-36.72B | -12.28%-143.33B | -13.56%-106.83B | -13.87%-70.28B | -13.08%-34.77B | -8.94%-127.65B | -8.08%-94.08B | -7.93%-61.72B |
Net service income | -20.56%15.17B | -21.66%10.53B | -24.80%5.5B | -11.39%23.7B | -11.39%19.1B | -9.37%13.45B | -4.99%7.31B | -2.09%26.74B | -0.79%21.55B | -1.13%14.84B |
-Service income | -19.21%17.25B | -20.40%11.85B | -22.91%6.18B | -11.15%26.72B | -9.79%21.35B | -8.42%14.89B | -5.44%8.02B | -0.18%30.08B | 0.03%23.67B | -0.41%16.26B |
-Service charge | 7.73%-2.08B | 8.67%-1.32B | 3.40%-682M | 9.21%-3.03B | -6.58%-2.25B | -1.48%-1.44B | 9.83%-706M | -18.32%-3.33B | -9.26%-2.11B | -7.82%-1.42B |
Dividend income | -13.73%44M | --0 | ---- | -10.20%44M | 168.42%51M | -50.00%1M | 0.00%1M | 104.17%49M | -20.83%19M | 100.00%2M |
Net transaction income | 2.87%2.65B | -16.91%1.69B | 27.72%986M | 30.89%3.23B | 33.20%2.58B | 53.75%2.03B | 33.33%772M | 12.63%2.47B | -1.37%1.94B | 7.24%1.32B |
Securities and investments income | 44.55%10.63B | 62.36%8.49B | 53.38%3.52B | 39.12%8.93B | 2.98%7.35B | 8.74%5.23B | 5.43%2.29B | -36.42%6.42B | -13.91%7.14B | 11.37%4.81B |
Net remittance | -102.76%-24M | -100.84%-6M | -509.68%-127M | 132.44%1.13B | 10,787.50%871M | 340.40%714M | 108.86%31M | 16,033.33%484M | 100.00%8M | -462.20%-297M |
Special items of operating revenue | 98.88%1.42B | 176.18%1.06B | 21.94%428M | -39.96%1.23B | -53.42%714M | -67.87%382M | -55.96%351M | 29.15%2.05B | 43.94%1.53B | 92.08%1.19B |
Operating revenue | -8.70%102.49B | -8.71%69.87B | -9.61%34.49B | -4.04%145.74B | -4.39%112.26B | -2.55%76.53B | -1.67%38.16B | -0.98%151.87B | 0.29%117.41B | 1.79%78.53B |
Operating expenses - before deducting impairment | 3.11%-30.36B | 3.80%-19.76B | 5.48%-9.45B | 2.91%-43.91B | -2.33%-31.34B | -1.41%-20.54B | 3.04%-10B | 0.69%-45.23B | 0.61%-30.62B | 4.65%-20.26B |
Operating profit before deducting impairment | -10.87%72.12B | -10.51%50.1B | -11.08%25.04B | -4.51%101.83B | -6.76%80.92B | -3.92%55.99B | -1.17%28.16B | -1.10%106.64B | 0.61%86.79B | 4.24%58.27B |
Impairment and provisions | 30.61%-24.64B | 23.68%-20.3B | 21.40%-10.06B | -2.96%-52.11B | 12.81%-35.51B | 8.37%-26.6B | 8.39%-12.8B | 7.64%-50.61B | 6.21%-40.73B | -1.09%-29.03B |
-Impairment losses of other assets | 30.61%-24.64B | 23.68%-20.3B | 21.40%-10.06B | -2.96%-52.11B | 12.81%-35.51B | 8.37%-26.6B | 8.39%-12.8B | 7.64%-50.61B | 6.21%-40.73B | -1.09%-29.03B |
Operating profit after deducting impairment | 4.57%47.48B | 1.41%29.81B | -2.48%14.98B | -11.26%49.72B | -1.41%45.41B | 0.49%29.39B | 5.77%15.36B | 5.65%56.03B | 7.53%46.06B | 7.56%29.25B |
Operating profit | 4.57%47.48B | 1.41%29.81B | -2.48%14.98B | -11.26%49.72B | -1.41%45.41B | 0.49%29.39B | 5.77%15.36B | 5.65%56.03B | 7.53%46.06B | 7.56%29.25B |
Share of profit from joint venture company | -53.85%12M | -54.55%10M | -53.33%7M | 157.14%36M | 149.06%26M | 168.75%22M | 162.50%15M | 30.00%-63M | -194.44%-53M | -357.14%-32M |
Earning before tax | 4.53%47.49B | 1.37%29.82B | -2.53%14.99B | -11.09%49.76B | -1.24%45.43B | 0.67%29.41B | 6.05%15.38B | 5.71%55.97B | 7.45%46.01B | 7.47%29.22B |
Tax | -18.24%-8.9B | -0.21%-5.21B | 14.72%-2.49B | 20.55%-8.68B | 18.55%-7.53B | 10.00%-5.19B | -9.68%-2.92B | -17.46%-10.93B | -22.13%-9.24B | -23.31%-5.77B |
After-tax profit from continuing operations | 1.81%38.59B | 1.61%24.61B | 0.33%12.5B | -8.80%41.08B | 3.11%37.91B | 3.30%24.22B | 5.23%12.45B | 3.21%45.04B | 4.30%36.76B | 4.18%23.45B |
Earning After tax | 1.81%38.59B | 1.61%24.61B | 0.33%12.5B | -8.80%41.08B | 3.11%37.91B | 3.30%24.22B | 5.23%12.45B | 3.21%45.04B | 4.30%36.76B | 4.18%23.45B |
Minority profit | -17.59%178M | -16.33%123M | -9.21%69M | 21.89%284M | 25.58%216M | 0.00%147M | -10.59%76M | 0.43%233M | 6.17%172M | 110.00%147M |
Profits attributable to shareholders | 1.92%38.41B | 1.72%24.49B | 0.39%12.43B | -8.96%40.79B | 3.00%37.69B | 3.32%24.07B | 5.34%12.38B | 3.23%44.81B | 4.29%36.59B | 3.85%23.3B |
Basic earnings per share | 0.00%0.57 | -2.63%0.37 | -5.26%0.18 | -16.22%0.62 | -3.39%0.57 | 0.00%0.38 | 0.00%0.19 | 4.23%0.74 | 5.36%0.59 | 2.70%0.38 |
Diluted earnings per share | 1.79%0.57 | 2.78%0.37 | 0.00%0.18 | -8.96%0.61 | 5.66%0.56 | 2.86%0.36 | 5.88%0.18 | 3.08%0.67 | 3.92%0.53 | 6.06%0.35 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.